There are few effective treatment options for women with ovarian cancer that no longer responds to initial treatments.  However, doctors from the Nordic Society of GYN Oncology are studying a few new treatments that may offer hope to these women.  The data in their clinical trial showed that adding tamoxifen (Nolvadex and others), which is a hormone treatment, to chemotherapy gave slightly better results. Tamoxifen is a worthwhile option for women with resistant ovarian cancer.

About these ads